Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Andrea, Kövesdi"'
Publikováno v:
Engineering Failure Analysis. 128:105567
New Gourna, Egypt became an iconic place of mud-brick architecture in the middle of the 20th century as a result of the work of Hassan Fathy. In the dry climate of Egypt, mud-brick is an almost perfect building material, but the change in the environ
Autor:
Bálint Tobiás, Peter Horvath, Andrea Kövesdi, Zsolt Nagy, Peter L. Lakatos, Gyöngyi Kirschner, Gergely Lakatos, István Takács, Kristóf Árvai, Bernadett Balla, János P. Kósa
Publikováno v:
Orvosi Hetilap. 157:1429-1437
Tyrosine kinase inhibitors are widely used for treatment of certain oncohematological diseases. Several clinical studies have confirmed that specific BCR-ABL tyrosine kinase inhibitors alter the physiological process of bone tissue in a complex and u
Autor:
Éva, Hadházi, Szabolcs, Takács, Gábor, Csikós, Adél, Homoki, Annamária, Czinkóczki, Krisztina, Törő, Andrea, Kövesdi, Rita, F. Földi
Publikováno v:
Journal of Mental Health & Psychosomatics / Mentálhigiéné és Pszichoszomatika; Jun2021, Vol. 22 Issue 2, p147-206, 60p
Autor:
Péter Lakatos, Bernadett Balla, Bálint Tobiás, Balázs Járay, János P. Kósa, Tamás Székely, Andrea Kövesdi, Barbara Kocsis-Deák, János Horányi, Kristóf Árvai
Publikováno v:
Endocrine Abstracts.
Autor:
Gyöngyi, Kirschner, Bernadett, Balla, János, Kósa, Péter, Horváth, Andrea, Kövesdi, Gergely, Lakatos, István, Takács, Zsolt, Nagy, Bálint, Tóbiás, Kristóf, Árvai, Péter, Lakatos
Publikováno v:
Orvosi hetilap. 157(36)
Tyrosine kinase inhibitors are widely used for treatment of certain oncohematological diseases. Several clinical studies have confirmed that specific BCR-ABL tyrosine kinase inhibitors alter the physiological process of bone tissue in a complex and u
Autor:
Bernadett Balla, Andrea Kövesdi, János P. Kósa, Zsolt Nagy, Peter L. Lakatos, Bálint Tobiás, Gyöngyi Kirschner, István Takács, Peter Horvath, Gergely Lakatos, Kristóf Árvai
Publikováno v:
Molecular Medicine Reports
Numerous clinical observations have confirmed that breakpoint cluster region-abelson fusion oncoprotein tyrosine kinase inhibitors used in leukemia treatment alter bone physiology in a complex manner. The aim of the present study was to analyze the w